dihexa hgf c met potentiator Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer | Molecular Cancer Dihexa 20mg Qty25 – NewBioRx
Dihexa 20mg Qty25 NewBioRx DIHEXA Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect Growth factors and their peptide mimetics for treatment of traumatic brain injury ScienceDirect
Pay in 4 interest-free payments of $5.93 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8


